Ultralife Corporation
ULBIIndustrialsNASDAQElectrical Equipment & Parts · Last scanned Sep 9, 2026
Scan Results
Daily timeframePart of the industrials sector, Ultralife Corporation (ULBI) is listed under Electrical Equipment & Parts. Valued at $99.0M, ULBI is a micro-cap name in its sector. The company operates in two segments, Battery & Energy Products and Communications Systems.
Market Cap
$99.0M
Beta
0.83
P/E (TTM)
—
P/E (Fwd)
6.60
EPS (TTM)
$-0.39
EPS (Fwd)
$0.90
ROE
-4.9%
ROA
2.1%
Cash
$6.7M
Total Debt
$47.5M
Free CF
$2.3M
52W Change
-8.5%
Annual Financials
Cash vs Debt
Where ULBI stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, ULBI finished 3.13% below its 150-day moving average ($6.39) and 1.12% below its 200-day moving average ($6.26). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ULBI overbought or oversold?
At the September 3, 2026 close, ULBI's RSI(14) was 13.9, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $6.7M in cash, though total debt stands at $47.5M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $2.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -4.9% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $131.8M (2022) to $191.2M (2025), reflecting a 45% increase over the period.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Ultralife Corporation's trajectory.